Marcio Souza
2022 - Praxis Precision Medicines
In 2022, Marcio Souza earned a total compensation of $6M as President and Chief Executive Officer at Praxis Precision Medicines, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $375,000 |
|---|---|
| Option Awards | $3,649,420 |
| Salary | $625,000 |
| Stock Awards | $1,340,140 |
| Other | $38,518 |
| Total | $6,028,078 |
Souza received $3.6M in option awards, accounting for 61% of the total pay in 2022.
Souza also received $375K in non-equity incentive plan, $625K in salary, $1.3M in stock awards and $38.5K in other compensation.
Rankings
In 2022, Marcio Souza's compensation ranked 502nd out of 5,542 executives tracked by ExecPay. In other words, Souza earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 502 out of 5,542 | 91st |
Division Manufacturing | 209 out of 3,000 | 93rd |
Major group Chemicals And Allied Products | 61 out of 1,350 | 96th |
Industry group Drugs | 49 out of 1,253 | 96th |
Industry Pharmaceutical Preparations | 35 out of 907 | 96th |
Source: SEC filing on April 26, 2024.
Souza's colleagues
We found one more compensation record of an executive who worked with Marcio Souza at Praxis Precision Medicines in 2022.
2022
Timothy Kelly
Praxis Precision Medicines
Chief Financial Officer
News
Praxis Precision Medicines CEO Marcio Souza's 2023 pay falls 65% to $2.1M
April 26, 2024
Praxis Precision Medicines CEO Marcio Souza's 2021 pay jumps 148% to $11M
April 14, 2022
PTC Therapeutics CEO Stuart Peltz's 2020 pay jumps 36% to $11M
April 29, 2021
PTC Therapeutics CEO Stuart Peltz's 2018 pay jumps 85% to $4M
April 25, 2019